Post

New research · Ophthalmology
Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2d
Cohort studyGraefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2026

Global, regional, and national burden of glaucoma, 1990-2023: a systematic analysis of the Global Burden of Disease Study 2023.

Yan Li, Hanxu Fang, Qinhui Yu … Xiangke Cao
Read paper
OphthalmologyCohort study

Global age-standardized glaucoma disability burden rate fell 39% from 1990 to 2023.

Global, regional, and national burden of glaucoma, 1990-2023: a systematic analysis of the Global Burden of Disease Study 2023.

Yan Li … Xiangke Cao
Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2026
Purpose

This study aims to characterize the spatiotemporal trends in the global glaucoma burden from 1990 to 2023 and project future trends to 2050, informing tailored prevention and control strategies across countries.

Methods

An age-period-cohort framework was further used to evaluate age, period, and cohort effects on glaucoma burden.

n = 204 countries and territories
Results

glaucoma's toll on healthy years lived, adjusted for population age, dropped substantially

-1.58EAPC %
Males
-1.25EAPC %
Females
More results

Males exhibited a steeper decline (estimated annual percentage change - 1.58%) than females (- 1.25%).

High- and middle-Socio-demographic Index countries neared the minimum burden by 2000 and 2010, respectively, while low-Socio-demographic Index countries showed persistent high rates with partial rebounds.

More results

The period 2000-2015 accounted for 41% of the total reduction.

Forecasts suggest a mean annual age-standardized disability-adjusted life-year decline of 1.2% from 2023 to 2050, yielding a 27.8% reduction without rebound.

“
Conclusion · 1 of 2

Glaucoma exhibits a trajectory of rising cases but declining rates, with significant Socio-demographic Index-related disparities.

Conclusion · 2 of 2

Low-Socio-demographic Index countries require AI-enabled mass screening and access to generic medications, middle-Socio-demographic Index countries need risk-stratified management and laser trabeculoplasty, and high-Socio-demographic Index countries should focus on normal-tension glaucoma in the elderly.

Read paper
0 comments

No comments yet. Be the first.

Related papers

LatestFoundational
AI / Informatics
0·962 for OCT
MerMED-FM was very accurate at diagnosing diseases using eye scans
AI / Informatics
0.98
Artificial intelligence's eyelid-height measurements matched doctors' manual measurements almost perfectly
AI / Informatics
92.1%
combining eye scans and photos correctly told benign from cancerous lesions apart nearly every time
Cohort Study
28.6%
recurred locally in more than 1 in 4 patients over years of follow-up
Cohort Study
-0.395
excision group's post-op eyelid fullness score was lower - greater improvement
Cohort Study
86.7%
of infants probed after 12 months still had unresolved tear duct blockage
Observational
16%
eyelid tissue in rosacea patients showed less of this key repair-signaling protein inside cell nuclei
Cohort Study
25%
about 1 in 4 treated cases had symptoms return after improving